DK3665176T3 - Faste former af 3-(5-fluorbenzofuran-3-yl)-4-(5-methyl-5h[1,3]dioxolo[4,5-f]indol-7-yl)pyrrol-2,5-dion - Google Patents

Faste former af 3-(5-fluorbenzofuran-3-yl)-4-(5-methyl-5h[1,3]dioxolo[4,5-f]indol-7-yl)pyrrol-2,5-dion Download PDF

Info

Publication number: DK3665176T3
Authority: DK; Denmark
Prior art keywords: fluorbenzofuran; dioxolo; dion; indol; pyrrole
Prior art date: 2017-08-11

Application number

DK18760168.7T

Other languages

English (en)

Inventor

Yamin Zhang

Original Assignee

Actuate Therapeutics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2017-08-11

Filing date

2018-08-10

Publication date

2024-03-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=63405430&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3665176(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2018-08-10 Application filed by Actuate Therapeutics Inc filed Critical Actuate Therapeutics Inc

2024-03-25 Application granted granted Critical

2024-03-25 Publication of DK3665176T3 publication Critical patent/DK3665176T3/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicinal Preparation (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)

DK18760168.7T 2017-08-11 2018-08-10 Faste former af 3-(5-fluorbenzofuran-3-yl)-4-(5-methyl-5h[1,3]dioxolo[4,5-f]indol-7-yl)pyrrol-2,5-dion DK3665176T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201762544277P	2017-08-11	2017-08-11
PCT/US2018/046203 WO2019032958A1 (en)	2017-08-11	2018-08-10	SOLID FORMS OF 3- (5-FLUOROBENZOFURAN-3-YL) -4- (5-METHYL-5H [1,3] DIOXOLO [4,5-F] INDOL-7-YL) PYRROLE-2,5-DIONE

Publications (1)

Publication Number	Publication Date
DK3665176T3 true DK3665176T3 (da)	2024-03-25

Family

ID=63405430

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK18760168.7T DK3665176T3 (da)	2017-08-11	2018-08-10	Faste former af 3-(5-fluorbenzofuran-3-yl)-4-(5-methyl-5h[1,3]dioxolo[4,5-f]indol-7-yl)pyrrol-2,5-dion

Country Status (16)

Country	Link
US (3)	US11136334B2 (da)
EP (1)	EP3665176B1 (da)
JP (3)	JP7424639B2 (da)
KR (3)	KR20250070131A (da)
CN (2)	CN117362305A (da)
AU (3)	AU2018313259B2 (da)
BR (1)	BR112020002892A2 (da)
CA (1)	CA3072240A1 (da)
DK (1)	DK3665176T3 (da)
ES (1)	ES2974328T3 (da)
FI (1)	FI3665176T3 (da)
IL (2)	IL313800A (da)
MX (3)	MX2020001547A (da)
PL (1)	PL3665176T3 (da)
PT (1)	PT3665176T (da)
WO (1)	WO2019032958A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX2020003431A (es)	2017-10-16	2020-07-29	Actuate Therapeutics Inc	Formas solidas de 3-(5-fluorobenzofuran-3-il)-4-(5-metil-5h-[1,3]d ioxolo[4,5-f]indol-7-il)pirrol- 2,5-diona.
CN112437663A (zh) *	2018-05-17	2021-03-02	开动疗法公司	用β型糖原合酶激酶3抑制剂治疗特发性肺纤维化
CN119630388A (zh) *	2022-06-27	2025-03-14	开动疗法公司	Elraglusib的口服剂型

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2446269T3 (es)	2006-12-19	2014-03-06	The Board Of Trustees Of The University Of Illinois	3-Benzofuranil-4-indolil-maleimidas como potentes inhibidores de GSK-3 para trastornos neurodegenerativos
KR101669707B1 (ko)	2009-12-23	2016-10-27	아르퀼 인코포레이티드	정제된 피롤로퀴놀리닐-피롤리딘-2,5-디온 조성물 및 이의 제조 방법 및 사용 방법

2018
- 2018-08-10 FI FIEP18760168.7T patent/FI3665176T3/fi active
- 2018-08-10 DK DK18760168.7T patent/DK3665176T3/da active
- 2018-08-10 US US16/638,303 patent/US11136334B2/en active Active
- 2018-08-10 EP EP18760168.7A patent/EP3665176B1/en active Active
- 2018-08-10 PL PL18760168.7T patent/PL3665176T3/pl unknown
- 2018-08-10 MX MX2020001547A patent/MX2020001547A/es unknown
- 2018-08-10 KR KR1020257015420A patent/KR20250070131A/ko active Pending
- 2018-08-10 BR BR112020002892-4A patent/BR112020002892A2/pt not_active Application Discontinuation
- 2018-08-10 KR KR1020207006706A patent/KR102700883B1/ko active Active
- 2018-08-10 CN CN202311213594.XA patent/CN117362305A/zh active Pending
- 2018-08-10 CA CA3072240A patent/CA3072240A1/en active Pending
- 2018-08-10 PT PT187601687T patent/PT3665176T/pt unknown
- 2018-08-10 IL IL313800A patent/IL313800A/en unknown
- 2018-08-10 IL IL272556A patent/IL272556B2/en unknown
- 2018-08-10 KR KR1020247014386A patent/KR20240063198A/ko not_active Ceased
- 2018-08-10 WO PCT/US2018/046203 patent/WO2019032958A1/en not_active Ceased
- 2018-08-10 JP JP2020530441A patent/JP7424639B2/ja active Active
- 2018-08-10 CN CN201880059690.4A patent/CN111247153B/zh active Active
- 2018-08-10 AU AU2018313259A patent/AU2018313259B2/en active Active
- 2018-08-10 ES ES18760168T patent/ES2974328T3/es active Active
2020
- 2020-02-07 MX MX2023005875A patent/MX2023005875A/es unknown
- 2020-02-07 MX MX2024003249A patent/MX2024003249A/es unknown
2021
- 2021-09-24 US US17/484,025 patent/US12145943B2/en active Active
2023
- 2023-02-23 AU AU2023201059A patent/AU2023201059B2/en active Active
- 2023-07-28 JP JP2023123302A patent/JP7778750B2/ja active Active
2024
- 2024-10-16 US US18/917,541 patent/US20250115616A1/en active Pending
2025
- 2025-04-28 AU AU2025202936A patent/AU2025202936A1/en active Pending
- 2025-10-06 JP JP2025168516A patent/JP2026012715A/ja active Pending

Also Published As

Publication number	Publication date
WO2019032958A1 (en)	2019-02-14
US20200223861A1 (en)	2020-07-16
AU2023201059B2 (en)	2025-04-03
EP3665176B1 (en)	2024-01-24
US20220009939A1 (en)	2022-01-13
PT3665176T (pt)	2024-03-13
JP7778750B2 (ja)	2025-12-02
CA3072240A1 (en)	2019-02-14
KR20200040799A (ko)	2020-04-20
BR112020002892A2 (pt)	2020-08-04
CN117362305A (zh)	2024-01-09
CN111247153B (zh)	2024-04-02
AU2018313259B2 (en)	2022-11-24
JP2026012715A (ja)	2026-01-27
FI3665176T3 (fi)	2024-03-20
MX2020001547A (es)	2020-08-03
KR20250070131A (ko)	2025-05-20
US20250115616A1 (en)	2025-04-10
JP2023156372A (ja)	2023-10-24
MX2023005875A (es)	2023-06-05
AU2018313259A1 (en)	2020-02-27
US11136334B2 (en)	2021-10-05
JP7424639B2 (ja)	2024-01-30
IL272556A (en)	2020-03-31
IL272556B1 (en)	2024-09-01
CN111247153A (zh)	2020-06-05
AU2025202936A1 (en)	2025-05-15
ES2974328T3 (es)	2024-06-26
PL3665176T3 (pl)	2024-06-17
KR102700883B1 (ko)	2024-09-02
US12145943B2 (en)	2024-11-19
EP3665176A1 (en)	2020-06-17
MX2024003249A (es)	2024-04-04
JP2020530497A (ja)	2020-10-22
IL313800A (en)	2024-08-01
KR20240063198A (ko)	2024-05-09
IL272556B2 (en)	2025-01-01
AU2023201059A1 (en)	2023-03-23

Publication	Publication Date	Title
IL272748B (en)	2022-10-01	3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and their use
EP3700458C0 (en)	2023-06-07	OTHER BITE ADJUSTMENT STRUCTURES
EP3490474A4 (en)	2019-08-28	ORTHOPEDIC TIED IMPLANTS AND SYSTEM
SG11202007898XA (en)	2020-10-29	Kir3dl3 as an hhla2 receptor, anti-hhla2 antibodies, and uses thereof
EP3747922A4 (en)	2020-12-23	COMPOSITION OF SEQUENCED COPOLYMER
EP3858881A4 (en)	2022-07-06	NON-FLUORINATED BLOCK COPOLYMER
EP3432837C0 (en)	2023-08-30	MANDIBULE STENT IMPLANT, IMPLANT SYSTEM AND SURGICAL KIT
DK3402783T3 (da)	2020-05-04	3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decan-derivater
HUE055578T2 (hu)	2021-12-28	Temporo-mandibuláris protézis
IL272075A (en)	2020-03-31	Method, device and kit for preparing PRP
DK3618294T3 (da)	2021-05-03	Implanterbar batterianordning til standard cochlear implantat
BR112016018371A2 (pt)	2017-10-17	derivado de indolona substituído com pirrol, método de preparação do mesmo, composição compreendendo o mesmo e uso do mesmo
MX382092B (es)	2025-03-04	Compuestos heterocíclicos para el tratamiento de enfermedades.
EP3635532A4 (en)	2021-03-17	ADJUSTING SPEAKER VOLUME LEVELS
EP3461828A3 (en)	2019-05-01	Methods of preparing toll-like receptor modulators
PT3665176T (pt)	2024-03-13	Formas sólidas de 3-(5-fluorobenzofurano-3-il)-4-(5-metil-5h[1,3]dioxolo[4,5-f]indol-7-il)pirrol-2,5-diona
DK3283064T3 (da)	2019-08-12	Derivater til anvendelse i behandling af muskelatrofi
DK3697794T3 (da)	2026-02-02	Faste former af 3-(5-fluorbenzofuran-3-yl)-4-(5-methyl-5h-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dion
PL3645513T3 (pl)	2022-12-19	Pochodne benzoazepiny
CL2018000472S1 (es)	2018-06-29	Prótesis dental
EP3994168A4 (en)	2023-04-05	ANTIBODIES AGAINST LEPTIN RECEPTOR
EP3613714A4 (en)	2020-05-13	COMPOSITION FOR ARTIFICIAL MARBLE AND ARTIFICIAL MARBLE
EP3585361A4 (en)	2020-12-23	ARTIFICIAL SALIVA, RELATED PROCESSES AND USES
DK3363405T3 (da)	2021-10-04	Kæbeortopædisk tandstillingsreguleringsanordning
HK40033032A (en)	2021-04-01	Implant evaluation using acoustic emissions